277 related articles for article (PubMed ID: 30477353)
21. Transplanting Mesenchymal Stem Cells for Treatment of Ischemic Stroke.
Wang F; Tang H; Zhu J; Zhang JH
Cell Transplant; 2018 Dec; 27(12):1825-1834. PubMed ID: 30251564
[TBL] [Abstract][Full Text] [Related]
22. Extracellular Vesicles Improve Post-Stroke Neuroregeneration and Prevent Postischemic Immunosuppression.
Doeppner TR; Herz J; Görgens A; Schlechter J; Ludwig AK; Radtke S; de Miroschedji K; Horn PA; Giebel B; Hermann DM
Stem Cells Transl Med; 2015 Oct; 4(10):1131-43. PubMed ID: 26339036
[TBL] [Abstract][Full Text] [Related]
23. Promoting neuroregeneration after perinatal arterial ischemic stroke: neurotrophic factors and mesenchymal stem cells.
Wagenaar N; de Theije CGM; de Vries LS; Groenendaal F; Benders MJNL; Nijboer CHA
Pediatr Res; 2018 Jan; 83(1-2):372-384. PubMed ID: 28949952
[TBL] [Abstract][Full Text] [Related]
24. Intra-Arterial Transplantation of Allogeneic Mesenchymal Stem Cells Mounts Neuroprotective Effects in a Transient Ischemic Stroke Model in Rats: Analyses of Therapeutic Time Window and Its Mechanisms.
Toyoshima A; Yasuhara T; Kameda M; Morimoto J; Takeuchi H; Wang F; Sasaki T; Sasada S; Shinko A; Wakamori T; Okazaki M; Kondo A; Agari T; Borlongan CV; Date I
PLoS One; 2015; 10(6):e0127302. PubMed ID: 26075717
[TBL] [Abstract][Full Text] [Related]
25. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine.
Caplan AI
J Cell Physiol; 2007 Nov; 213(2):341-7. PubMed ID: 17620285
[TBL] [Abstract][Full Text] [Related]
26. Functional recovery after hematic administration of allogenic mesenchymal stem cells in acute ischemic stroke in rats.
Gutiérrez-Fernández M; Rodríguez-Frutos B; Alvarez-Grech J; Vallejo-Cremades MT; Expósito-Alcaide M; Merino J; Roda JM; Díez-Tejedor E
Neuroscience; 2011 Feb; 175():394-405. PubMed ID: 21144885
[TBL] [Abstract][Full Text] [Related]
27. Clinical Trials of Stem Cell Therapy for Cerebral Ischemic Stroke.
Kawabori M; Shichinohe H; Kuroda S; Houkin K
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33036265
[TBL] [Abstract][Full Text] [Related]
28. [Bone marrow stem cell therapy for stroke].
Sasaki Y; Honmou O
Nihon Rinsho; 2011 Dec; 69(12):2203-8. PubMed ID: 22242320
[TBL] [Abstract][Full Text] [Related]
29. Tissue source determines the differentiation potentials of mesenchymal stem cells: a comparative study of human mesenchymal stem cells from bone marrow and adipose tissue.
Xu L; Liu Y; Sun Y; Wang B; Xiong Y; Lin W; Wei Q; Wang H; He W; Wang B; Li G
Stem Cell Res Ther; 2017 Dec; 8(1):275. PubMed ID: 29208029
[TBL] [Abstract][Full Text] [Related]
30. Adipose tissue-derived mesenchymal stem cells as a strategy to improve recovery after stroke.
Gutiérrez-Fernández M; Otero-Ortega L; Ramos-Cejudo J; Rodríguez-Frutos B; Fuentes B; Díez-Tejedor E
Expert Opin Biol Ther; 2015 Jun; 15(6):873-81. PubMed ID: 25959243
[TBL] [Abstract][Full Text] [Related]
31. Hypoxia and interleukin-1-primed mesenchymal stem/stromal cells as novel therapy for stroke.
Salaudeen MA; Allan S; Pinteaux E
Hum Cell; 2024 Jan; 37(1):154-166. PubMed ID: 37987924
[TBL] [Abstract][Full Text] [Related]
32. Transplantation of bone marrow-derived stem cells: a promising therapy for stroke.
Tang Y; Yasuhara T; Hara K; Matsukawa N; Maki M; Yu G; Xu L; Hess DC; Borlongan CV
Cell Transplant; 2007; 16(2):159-69. PubMed ID: 17474297
[TBL] [Abstract][Full Text] [Related]
33. Enhancing Retention of Human Bone Marrow Mesenchymal Stem Cells with Prosurvival Factors Promotes Angiogenesis in a Mouse Model of Limb Ischemia.
Cortez-Toledo E; Rose M; Agu E; Dahlenburg H; Yao W; Nolta JA; Zhou P
Stem Cells Dev; 2019 Jan; 28(2):114-119. PubMed ID: 30398391
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of stem cell-based therapies for stroke.
Chrostek MR; Fellows EG; Crane AT; Grande AW; Low WC
Brain Res; 2019 Nov; 1722():146362. PubMed ID: 31381876
[TBL] [Abstract][Full Text] [Related]
35. Concise Review: Mesenchymal Stem Cells in Cardiovascular Regeneration: Emerging Research Directions and Clinical Applications.
Majka M; Sułkowski M; Badyra B; Musiałek P
Stem Cells Transl Med; 2017 Oct; 6(10):1859-1867. PubMed ID: 28836732
[TBL] [Abstract][Full Text] [Related]
36. Mesenchymal Stem Cells: Therapeutic Mechanisms for Stroke.
Zhang Y; Dong N; Hong H; Qi J; Zhang S; Wang J
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269692
[TBL] [Abstract][Full Text] [Related]
37. Recent Advances in Endocrine, Metabolic and Immune Disorders: Mesenchymal Stem Cells (MSCs) and Engineered Scaffolds.
Cantore S; Crincoli V; Boccaccio A; Uva AE; Fiorentino M; Monno G; Bollero P; Derla C; Fabiano F; Ballini A; Santacroce L
Endocr Metab Immune Disord Drug Targets; 2018; 18(5):466-469. PubMed ID: 29692270
[TBL] [Abstract][Full Text] [Related]
38. Regenerative therapy for stroke.
Chang YC; Shyu WC; Lin SZ; Li H
Cell Transplant; 2007; 16(2):171-81. PubMed ID: 17474298
[TBL] [Abstract][Full Text] [Related]
39. Bone marrow mesenchymal stem cells suppress IL-9 in adjuvant-induced arthritis.
Abd-Elhalem SS; Haggag NZ; El-Shinnawy NA
Autoimmunity; 2018 Feb; 51(1):25-34. PubMed ID: 29359591
[TBL] [Abstract][Full Text] [Related]
40. Comparative Characterization of Ischemia-Induced Brain Multipotent Stem Cells with Mesenchymal Stem Cells: Similarities and Differences.
Sakuma R; Takahashi A; Nakano-Doi A; Sawada R; Kamachi S; Beppu M; Takagi T; Yoshimura S; Matsuyama T; Nakagomi T
Stem Cells Dev; 2018 Oct; 27(19):1322-1338. PubMed ID: 29999479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
